Boehringer Ingelheim Investigational Site

Dublin

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
• Tiotropium / Respimat One-Year Study — Completed